Literature DB >> 191876

Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

R R Gorman, S Bunting, O V Miller.   

Abstract

Prostacyclin (PGX) (57)-9-deoxy-6,9alpha-epoxy-delta5-PGF1alpha has been found to be a potent stimulator of cAMP accumulation in platelets than PGE1. The prostacyclin stimulation of platelet cAMP accumulation can be antagonized by the prostaglandin endoperoxide PGH2, and a PGH2-induced platelet aggregation is antagonized by prostacyclin. A model of platelet homeostasis is proposed that suggests platelet aggregation is controlled by a balance between the adenylate cyclase stimulating activity of prostacyclin, and the cAMP lowering activity of PGH2.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191876     DOI: 10.1016/0090-6980(77)90018-1

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  96 in total

1.  Internalization and down-regulation of the prostacyclin receptor in human platelets.

Authors:  S Giovanazzi; M R Accomazzo; O Letari; D Oliva; S Nicosia
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Prostaglandins and the human mucosal alimentary cyclic AMP system.

Authors:  B Simon; H Kather
Journal:  Dig Dis Sci       Date:  1979-12       Impact factor: 3.199

3.  Pharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in man.

Authors:  W Krause; T Krais
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man.

Authors:  H Sinzinger; F Rauscha; J O'Grady; P Fitscha
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

5.  The effect of prostacyclin on cerebral vasospasm. An experimental study.

Authors:  L Quintana; R Konda; Y Ishibashi; T Yoshimoto; J Suzuki
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

6.  Role of hydrogen peroxide in the neutrophil-mediated release of prostacyclin from cultured endothelial cells.

Authors:  J M Harlan; K S Callahan
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

7.  Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.

Authors:  G B Burns; J A Dodge
Journal:  Agents Actions       Date:  1984-01

8.  Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture.

Authors:  A J de Brum-Fernandes; S Morisset; G Bkaily; C Patry
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

9.  Anti-aggregatory effect of prostacyclin (PGI2) in vivo.

Authors:  B L Bayer; K E Blass; W Förster
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

10.  Selective binding site for [3H]prostacyclin on platelets.

Authors:  A M Siegl; J B Smith; M J Silver; K C Nicolaou; D Ahern
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.